Lannett reported $-13028000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US USD 4.6B 1.31B
Amerisourcebergen ABC:US USD 633.14M 188.52M
Ani Pharmaceuticals ANIP:US USD -4995000 7.92M
Aurora Cannabis Inc ACB:CN CAD -54500000 570.08M
Canopy Growth Corp WEED:CN CAD -159665000 1.7B
Cardinal Health CAH:US USD 137M 101M
Corcept Therapeutics CORT:US USD 31.93M 502K
Depomed DEPO:US USD 6.43M 4.36M
Endo International Ordinary Shares ENDP:US USD -636822000 1.1B
Knight Therapeutics Inc GUD:CN CAD -11333000 14.22M
Ligand Pharmaceuticals LGND:US USD 636K 695K
Mckesson MCK:US USD 1.24B 117M
Nektar Therapeutics NKTR:US USD -54301000 98.54M
Novartis NVS:US USD 1.95B 219M
Omeros OMER:US USD -50766000 13.33M
Pacira Pharmaceuticals PCRX:US USD 21.29M 9.95M
Perrigo Ordinary Shares PRGO:US USD 33.5M 49.7M
Pfizer PFE:US USD 5.17B 4.24B
Prestige Brands PBH:US USD 84.38M 2.63M
Supernus Pharmaceuticals SUPN:US USD -1523000 12.87M
Teva Pharmaceutical TEVA:IT USD 419M 1.37B
Zoetis ZTS:US USD 667M 3M